- Info
- Significant Ownership
- Insider Ownership
- Insider Trading
- Financials
- Holders
Significant Ownership of Roivant Sciences Ltd.
- Signature - Title
- /s/ Keyur Parekh - Keyur Parekh, Authorized Signatory
- Location
- London
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Roivant Sciences Ltd..
Follow Filing Activity
Follow Roivant Sciences Ltd. and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Roivant Sciences Ltd.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Common Stock, par value $0.0001 per share | 56% | $2,812,776,314 | +$413,666,650 | 113,327,007 | +17% | Roivant Sciences Ltd. | 12 Dec 2025 |
| ABUS | Arbutus Biopharma Corp | Common Shares, without par value | 20% | $127,808,150 | 38,847,462 | 0% | Roivant Sciences Ltd. | 21 Feb 2025 |
Schedules 13D/G Reported by Roivant Sciences Ltd.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.